These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain. Klauke AL; Racz I; Pradier B; Markert A; Zimmer AM; Gertsch J; Zimmer A Eur Neuropsychopharmacol; 2014 Apr; 24(4):608-20. PubMed ID: 24210682 [TBL] [Abstract][Full Text] [Related]
7. Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise. Sharma C; Al Kaabi JM; Nurulain SM; Goyal SN; Kamal MA; Ojha S Curr Pharm Des; 2016; 22(21):3237-64. PubMed ID: 26965491 [TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development. Pertwee RG Expert Opin Investig Drugs; 2000 Jul; 9(7):1553-71. PubMed ID: 11060760 [TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptors and their ligands. Pertwee RG; Ross RA Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030 [TBL] [Abstract][Full Text] [Related]
10. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells. Chiba T; Ueno S; Obara Y; Nakahata N J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165 [TBL] [Abstract][Full Text] [Related]
11. β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19. Jha NK; Sharma C; Hashiesh HM; Arunachalam S; Meeran MN; Javed H; Patil CR; Goyal SN; Ojha S Front Pharmacol; 2021; 12():590201. PubMed ID: 34054510 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis. Tambaro S; Casu MA; Mastinu A; Lazzari P Eur J Pharmacol; 2014 Apr; 729():67-74. PubMed ID: 24561047 [TBL] [Abstract][Full Text] [Related]
13. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease. Gómez-Gálvez Y; Palomo-Garo C; Fernández-Ruiz J; García C Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():200-8. PubMed ID: 25863279 [TBL] [Abstract][Full Text] [Related]
14. The therapeutic potential of novel cannabinoid receptors. Kreitzer FR; Stella N Pharmacol Ther; 2009 May; 122(2):83-96. PubMed ID: 19248809 [TBL] [Abstract][Full Text] [Related]
15. LPS-mediated neutrophil VEGF-A release is modulated by cannabinoid receptor activation. Braile M; Cristinziano L; Marcella S; Varricchi G; Marone G; Modestino L; Ferrara AL; De Ciuceis A; Scala S; Galdiero MR; Loffredo S J Leukoc Biol; 2021 Mar; 109(3):621-631. PubMed ID: 32573828 [TBL] [Abstract][Full Text] [Related]
16. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects. de Lago E; Moreno-Martet M; Cabranes A; Ramos JA; Fernández-Ruiz J Neuropharmacology; 2012 Jun; 62(7):2299-308. PubMed ID: 22342378 [TBL] [Abstract][Full Text] [Related]
17. Towards a therapeutic use of selective CB2 cannabinoid receptor ligands for atherosclerosis. Steffens S; Mach F Future Cardiol; 2006 Jan; 2(1):49-53. PubMed ID: 19804131 [TBL] [Abstract][Full Text] [Related]
18. Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice. Ueda Y; Miyagawa N; Matsui T; Kaya T; Iwamura H Eur J Pharmacol; 2005 Sep; 520(1-3):164-71. PubMed ID: 16153638 [TBL] [Abstract][Full Text] [Related]
19. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Ibrahim MM; Porreca F; Lai J; Albrecht PJ; Rice FL; Khodorova A; Davar G; Makriyannis A; Vanderah TW; Mata HP; Malan TP Proc Natl Acad Sci U S A; 2005 Feb; 102(8):3093-8. PubMed ID: 15705714 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of pain responses by activation of CB(2) cannabinoid receptors. Malan TP; Ibrahim MM; Vanderah TW; Makriyannis A; Porreca F Chem Phys Lipids; 2002 Dec; 121(1-2):191-200. PubMed ID: 12505700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]